Animal Drug Compounding Market To Take An Upward Turn In The Next DecadePosted by Merin John on June 14th, 2021 Scarce availability of FDA-approved drug formulations for diseases in animals is mended through animal drug compounding, with varied formulations and administration of desired active ingredients. Furthermore, compounded animal drugs are available in alternate dosage forms and dosage strengths, unlike branded veterinary drugs that often come in a single dosage or strength. Many drugs contain flavoured formulations for the purpose of increasing palatability and compliance. This is done by changing the gritty texture into a smooth and creamy consistency. Abnormal limb coordination, seizures, behavioural changes and blindness in animals such as dogs and cats is commonly observed. CNS drugs are most frequently dispensed in order to treat neurological disorders in animals, and account for the highest demand as far as animal drug compounding is concerned. Persistence Market Research predicts that the global market for animal drug compounding will be valued at close to US$ 1.9 Bn in 2021, and expand at an 8% CAGR over the forecast period (2021-2031). Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/12871 Key Takeaways from Market Study
“Unavailability of commercially produced branded drugs in the market with specific and desired formulations is set to fuel demand for compounded drug formulations over the years to come” says the Persistence Market Research analyst. Like it? Share it!More by this author |